Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page version updated from v3.0.1 to v3.0.2. The Back to Top element was removed, with no changes to core content.
    Difference
    0.1%
    Check dated 2025-09-14T21:51:43.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has updated the publication date of a significant clinical trial article from May 8, 2025, to July 1, 2025, and has revised the version number from v3.0.0 to v3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T18:24:11.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a significant publication related to a clinical trial involving pembrolizumab for metastatic triple negative breast cancer. Additionally, the revision number has been updated to v3.0.0.
    Difference
    5%
    Check dated 2025-08-31T12:26:24.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T04:41:05.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-10T00:32:38.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-01T18:56:45.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.